Ruthenium(ii) polypyridyl complexes with visible light-enhanced anticancer activity and multimodal cell imaging

被引:2
|
作者
Kang, Yan [1 ,2 ,3 ,4 ,5 ,6 ]
Zhao, Yao [1 ,2 ,3 ,4 ,7 ,8 ]
Wei, Yuanyuan [1 ,2 ,3 ,4 ,5 ]
Zhang, Yang [1 ,2 ,3 ,4 ,7 ]
Wang, Zhaoying [1 ,2 ,3 ,4 ,7 ]
Luo, Qun [1 ,2 ,3 ,4 ,7 ]
Du, Jun [5 ]
Wang, Fuyi [1 ,2 ,3 ,4 ,7 ]
机构
[1] Chinese Acad Sci, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, CAS Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China
[3] Chinese Acad Sci, Natl Ctr Mass Spectrometry Beijing, Beijing 100190, Peoples R China
[4] Chinese Acad Sci, Inst Chem, Beijing 100190, Peoples R China
[5] Anhui Normal Univ, Coll Chem & Mat Sci, Key Lab Funct Mol Solids, Anhui Lab Mol Based Mat,Minist Educ, Wuhu 241000, Peoples R China
[6] Natl Univ Def Technol, Coll Adv Interdisciplinary Studies, Changsha 410073, Peoples R China
[7] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[8] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
EPIDERMAL-GROWTH-FACTOR; METAL-COMPLEXES; IN-VITRO; DNA; LIGANDS; SINGLE; APOPTOSIS; RECEPTOR; THERAPY; DRUG;
D O I
10.1039/d3dt01661g
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Ruthenium(ii) polypyridyl complexes have drawn growing attention due to their photophysical properties and anticancer activity. Herein we report four ruthenium(ii) polypyridyl complexes [(N<^>N)(2)Ru-II(L)](2+) (1-4, L = 4-anilinoquinazoline derivatives, N<^>N = bidentate ligands with bis-nitrogen donors) as multi-functional anticancer agents. The epidermal growth factor receptor (EGFR) is overexpressed in a broad range of cancer cells and related to many kinds of malignance. EGFR inhibitors, such as gefitinib and erlotinib, have been approved as clinical anticancer drugs. The EGFR-inhibiting 4-anilinoquinazoline ligands greatly enhanced the in vitro anticancer activity of these ruthenium(ii) polypyridyl complexes against a series of human cancer cell lines compared to [Ru(bpy)(2)(phen)], but interestingly, these complexes were actually not potent EGFR inhibitors. Further mechanism studies revealed that upon irradiation with visible light, complexes 3 and 4 generated a high level of singlet oxygen (O-1(2)), and their in vitro anticancer activities against human non-small-cell lung (A549), cervical (HeLa) and squamous (A431) cancer cells were significantly improved. Specifically, complex 3 displayed potent phototoxicity upon irradiation with blue light, of which the photo-toxicity indexes (PIs) against HeLa and A431 cells were 11 and 8.3, respectively. These complexes exhibited strong fluorescence emission at ca. 600 nm upon excitation at about 450 nm. A subcellular distribution study by fluorescence microscopy imaging and secondary ion mass spectrometry imaging (ToF-SIMS) demonstrated that complex 3 mainly localized at the cytoplasm and complex 4 mainly localized in the nuclei of cells. Competitive binding with ctDNA showed that complex 4 was more favorable to bind to the DNA minor groove than complex 3. These differences support that complex 3 possibly exerts its anticancer activities majorly by photo-induced O-1(2) generation and complex 4 by binding to DNA.
引用
收藏
页码:12478 / 12489
页数:12
相关论文
共 50 条
  • [41] Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest
    Li, Yu-Lan
    Zhu, Xiao-Min
    Chen, Nan-Feng
    Chen, Shao-Ting
    Yang, Yang
    Liang, Hong
    Chen, Zhen-Feng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [42] Ruthenium Polypyridyl Complexes Hopping at Anionic Lipid Bilayers through a Supramolecular Bond Sensitive to Visible Light
    Bahreman, Azadeh
    Limburg, Bart
    Siegler, Maxime A.
    Koning, Roman
    Koster, Abraham J.
    Bonnet, Sylvestre
    CHEMISTRY-A EUROPEAN JOURNAL, 2012, 18 (33) : 10271 - 10280
  • [43] Anticancer activity of heterodinuclear ruthenium(II)-platinum(II) complexes as photochemotherapeutic agents
    Yano, Takakazu
    Hishida, Shota
    Nakai, Misaki
    Nakabayashi, Yasuo
    INORGANICA CHIMICA ACTA, 2017, 454 : 162 - 170
  • [44] Synthesis, characterization and structure-activity relationships of novel ruthenium(II) polypyridyl complexes
    Narh, Eugenia S.
    MacDonnell, Frederick M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [45] Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes
    Du, Ke-Jie
    Wang, Jin-Quan
    Kou, Jun-Feng
    Li, Guan-Ying
    Wang, Li-Li
    Chao, Hui
    Ji, Liang-Nian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (04) : 1056 - 1065
  • [46] Ruthenium(II) polypyridyl complexes synthesis and studies of DNA binding, photocleavage, cytotoxicity activity
    Kumar, Yata Praveen
    Satyanarayana, Sirasani
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [47] Study of synergetic effect between BODIPY and ZnO on visible light-enhanced antibacterial activity
    Lin, Chao
    Dong, Ying
    Chen, Cheng
    Chen, Qiu-Yun
    Li, Shi-Jie
    Du, Huan
    Qu, Ling-Ling
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2024, 453
  • [48] Anticancer activity of ruthenium(II) polypyridine complexes bearing pyrrolidine substituents
    Mazuryk, Olga
    Lomzik, Michal
    Martineau, David
    Beley, Marc
    Brindell, Malgorzata
    Stochel, Grazyna
    Gros, Philippe C.
    INORGANICA CHIMICA ACTA, 2016, 443 : 86 - 90
  • [49] Ruthenium(II)-mercapto Complexes with Anticancer Activity Interact with Topoisomerase IB
    da Silva, Monize M.
    de Camargo, Mariana S.
    Castelli, Silvia
    de Grandis, Rone A.
    Castellano, Eduardo E.
    Deflon, Victor M.
    Cominetti, Marcia R.
    Desideri, Alessandro
    Batista, Alzir A.
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2020, 31 (03) : 536 - 549
  • [50] Combination of light and Ru(II) polypyridyl complexes: Recent advances in the development of new anticancer drugs
    Conti, Luca
    Macedi, Eleonora
    Giorgi, Claudia
    Valtancoli, Barbara
    Fusi, Vieri
    COORDINATION CHEMISTRY REVIEWS, 2022, 469